Item

Number %

Gender

Male

Female

21 (48.8%)

22 (51.2%)

Age

Range (years)

Mean ± SD

40 - 70

55.9 ± 9.2

Smoking

Yes

No

21 (48.8%)

22 (51.2%)

Performance status

0/1

2

28 (65.1%)

15 (34.9%)

Sites

Larynx

Oropharynx

Hypopharynx

26 (60.5%)

10 (23.3%)

7 (16.2%)

Subsites

Glottic

Supraglottic

Tongue

Post cricoid

15 (34.9%)

11 (25.6%)

11 (25.6%)

6 (13.9%)

Tumor size

T1

T2

T3

T4

0 (0%)

21 (48.8%)

17 (39.6%)

5 (11.6%)

Lymph nodes

N0

N1

N2

N3

15 (34.9%)

15 (34.9%)

9 (20.9%)

4 (9%.3)

Stage

II

III

Iva&b

15 (34.9%)

9 (20.9%)

19 (44.1%)

Treatment modalities

Definitive radiotherapy

Induction chemotherapy followed by CCRTH

CCRTH

15 (34.9%)

9 (20.9%)

19 (44.1%)